G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map (2012)

Peer-Reviewed Study · Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, Hogg MM, Battle KE, Padilla CD, Baird JK, Hay SI · November 13, 2012

Howes RE et al., 2012-11-13: The standard global estimate: G6PD deficiency allele frequency of 8.0% across malaria-endemic countries, corresponding to about 220 million males and 133 million females – roughly 350 million people, not 400 million, and only within malaria-endemic countries.

We estimated overall G6PDd allele frequency across MECs to be 8.0% (IQR: 7.4-8.8); using 2010 population data ( Protocol S4 ), this corresponded to 220 million males (IQR: 203-241) and an estimated 133 million females (122-148), including 17 million homozygous females

Results (population estimates paragraph)

Howes RE et al., 2012-11-13: The standard global estimate: G6PD deficiency allele frequency of 8.0% across malaria-endemic countries, corresponding to about 220 million males and 133 million females – roughly 350 million people, not 400 million, and only within malaria-endemic countries. C3 prevalence element. The widely quoted "about 400 million people worldwide" is NOT what this primary source says: its figure is ~353 million (220m males + 133m females) across malaria-endemic countries, with the paper's own summary text saying "about 350 million affected individuals". The 400 million figure therefore appears to be an upward rounding/extension to "worldwide" rather than a transcription of this source. Funder/conflicts: not read in full (PMC HTML/XML available). Quote is from the PMC full-text XML, verified as a single continuous span. Study type: other.